EMC Instytut Medyczny SA is a Poland-based company that operates a network of private hospitals and health centers in Poland and in Ireland. The Company offers a range of services, including the professional treatment of obesity, hernia, knee surgery, hip replacement and various plastic surgeries. It also provides such diagnostic services as laboratory tests, diagnostic imaging (X-ray and ultrasonography), colonoscopy, gastroscopy and capsule endoscopy, as well as consultancy services with a range of specialists. In addition, it provides the prophylaxis programs. The Company operates hospitals and outpatient specialty and care clinics. It operates such subsidiaries as: Lubmed Sp z o o, Mikulicz Sp z o o, EMC Silesia Sp z o o, PCZ Kowary Sp z o o and EMC Health Care Limited, among others. On January 3, 2014, CareUp BV acquired 68.41% stake in the Company due to the acquisition of Soporto Invest BV. On February 11, 2014, the Company acquired Regionalne Centrum Zdrowia Sp z o o.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.